Annovis Bio Inc (NYSE:ANVS) price on Friday, June 13, fall -4.42% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.81.
A look at the stock’s price movement, the close in the last trading session was $2.94. Turning to its 52-week performance, $17.88 and $1.11 were the 52-week high and 52-week low respectively. Overall, ANVS moved 66.27% over the past month.
Annovis Bio Inc’s market cap currently stands at around $54.76 million, with investors looking forward to this quarter’s earnings report slated for in July.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ANVS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ANVS’s current price about 11.11% and 49.26% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.26, while 7-day volatility ratio is 4.86% and 8.48% in the 30-day chart. Further, Annovis Bio Inc (ANVS) has a beta value of 1.63, and an average true range (ATR) of 0.29. Analysts have given the company’s stock an average 52-week price target of $26, forecast between a low of $21 and high of $30. Looking at the price targets, the low is -647.33% off current price level while to achieve the yearly target high, price needs to move -967.62%. Nonetheless, investors will most likely welcome a -825.27% jump to $26 which is the analysts’ median price.
If we refocus on Annovis Bio Inc (NYSE:ANVS), historical trading data shows that trading volumes averaged 438.44K over the past 3 months. The company’s latest data on shares outstanding shows there are 19.49 million shares.
The 14.55% of Annovis Bio Inc’s shares are in the hands of company insiders while institutional holders own 15.84% of the company’s shares. Current price change has pushed the stock -44.14% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ANVS stock continues to rise going into the next quarter.
